Trials / Conditions / Anaplastic Ganglioglioma
Anaplastic Ganglioglioma
4 registered clinical trials studyying Anaplastic Ganglioglioma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Gra NCT03919071 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Pediatric Long-Term Follow-up and Rollover Study NCT03975829 | Novartis Pharmaceuticals | Phase 4 |
| Completed | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies fo NCT03434262 | St. Jude Children's Research Hospital | Phase 1 |
| Completed | Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 NCT02684058 | Novartis Pharmaceuticals | Phase 2 |